CHEO Research Institute Logo
Decrease Text SizeIncrease Text SizeFacebookTwitterYoutube

coordinators at a seminar  
What's New rss


20/2/2019

Media Advisory: CHEO Researcher and Medical Geneticist Dr. Kym Boycott to appear at UN Rare Disease Day Policy Event

OTTAWA February 20, 2019 – Dr. Kym Boycott, Medical Geneticist and Senior Scientist at CHEO and Professor of Pediatrics at the University of Ottawa, will be appearing at the United Nations Headquarters in New York on Thursday, February 21, 2019. She is presenting her world-renowned research and clinical work in genetics and rare disease as part of the Second High Level Event of the NGO Committee for Rare Disease. This is the first time CHEO has been represented at the UN.

Dr. Boycott will be part of the panel addressing the integrated approach between research and care; and between medical and social care. Dr. Boycott’s presentation, “Networks for Applying Research to Diagnosis and Care”, will draw on her experience in creating networks in Canada to diagnose unsolved rare disease and informing care as well as build the infrastructure and tools needed to improve rare disease diagnosis worldwide.

CHEO and the CHEO Research Institute are Canadian and world leaders in rare disease and genetics care and research. The organizations, affiliated with the University of Ottawa, are home to Care4Rare Canada. Dr. Boycott and her team do research into the more than 7,000 rare genetic diseases that have a devastating impact for the estimated one million Canadians and their families who are affected. The genetic cause is unknown for one-third of rare diseases (i.e., the rare disease is unsolved), preventing accurate diagnosis and informed care. In January 2018, Dr. Boycott and her team receive more than $12M from Genome Canada and CIHR for the project “Harnessing multi-omics to deliver innovative diagnostic care for rare genetic diseases in Canada (Care4Rare-SOLVE)”. The project works to identify the genetic causes of unsolved rare diseases and make genomic sequencing available to Canadians for diagnosis. In addition, Dr. Boycott received support from the Canada Foundation for Innovation in 2015 for an advanced genome sequencer that helped a nationwide network of doctors and researchers look for the genetic causes of rare diseases affecting children.

Dr. Boycott received the 2018 Pediatric Chairs of Canada Clinician Investigator Award. She was the first woman and youngest recipient of this award.

Dr. Boycott’s presentation will be livestreamed at approximately 15:15 at: http://webtv.un.org/

A photo of Dr. Boycott is available upon request.

For more information or to arrange an interview:
Aynsley Morris
Director of Communications
CHEO Research Institute
E-mail: amorris@cheo.on.ca
Phone: 613-737-7600 x 4144
Mobile: 613-914-3059


Take Action
Quick Links

Our Researchmagnifying glass

abcefg hijklmnopqrst uvwxyz